Medifast (MED) Misses Q4 EPS by 8c, Guidance Mixed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $0.38, $0.08 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $62.3 million versus the consensus estimate of $69.4 million.
Medifast sees FY2015 EPS of $1.85-$1.95, versus the consensus of $1.83. Medifast sees FY2015 revenue of $285-300 million, versus the consensus of $307.77 million.
Medifast sees Q1 2015 EPS of $0.33-$0.35, versus the consensus of $0.43. Medifast sees Q1 2015 revenue of $70-73 million, versus the consensus of $83.70 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
- Twin Disc (TWIN) Tops Q1 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
